Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands at the forefront of the biotechnology sector with an impressive market capitalization of $8.51 billion. The company, headquartered in Newark, California, has carved out..
NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to cancer treatment through Tumor Treating Fields (TTFields). Headquartered in Baar,..
Amneal Pharmaceuticals, Inc. (AMRX), a key player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, commands a significant presence in the global biopharmaceutical landscape...
Envista Holdings Corporation (NYSE: NVST) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.45 billion, Envista stands as..
Haemonetics Corporation (NYSE: HAE), a leader in medical technology specializing in blood management solutions, is capturing the attention of investors with its robust growth potential and favorable market position. Trading..
LifeStance Health Group, Inc. (LFST), a prominent player in the U.S. healthcare sector, has been making waves in the outpatient mental health services industry. With a market capitalization of $4.02..
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors as it navigates the dynamic landscape of biotechnology. With a focus on developing RNA interference-based therapies for intractable diseases,..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a notable player in the healthcare sector, particularly in the medical instruments and supplies industry, has been generating interest among investors with its compelling dividend..
ImmunityBio, Inc. (NASDAQ: IBRX) is catching the eyes of investors with its promising strides in the biotechnology sector, focusing on next-generation immunotherapies. With a market capitalization of $7.49 billion, this..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a noteworthy player in the biotechnology sector, focused on developing treatments for rare and ultra-rare genetic diseases. With a market capitalization of $2.46..
